Ophthalmology vs Dermatology — Deal Terms Comparison

Ophthalmology Median Upfront

$768M

Total: $3.6B

Dermatology Median Upfront

$393M

Total: $2.1B

Ophthalmology Royalties

10.2%-20.4%

Tiered to 24.4%

Dermatology Royalties

6.5%-13.1%

Tiered to 17.1%

Model Your Deal

Market Analysis

Ophthalmology and Dermatology represent distinct licensing landscapes with different risk-reward dynamics. Phase 2 ophthalmology deals carry a median total deal value of $3.6B with $768M upfront, compared to $2.1B total value and $393M upfront for dermatology. The differences reflect divergent clinical development timelines, regulatory pathways, and addressable market sizes.

Deal structures differ across therapeutic areas. Ophthalmology deals allocate 21% to upfront and 79% to milestones, while Dermatology deals split 19%/81%. Development milestones are $569M for ophthalmology versus $345M for dermatology, reflecting the different clinical trial designs and approval standards in each area.

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How do ophthalmology and dermatology deal terms compare?

Ophthalmology Phase 2 deals average $3.6B total value ($768M upfront), while Dermatology deals average $2.1B ($393M upfront). The differences are driven by addressable market size, clinical development complexity, and regulatory pathway characteristics.

Which therapeutic area commands higher royalty rates: Ophthalmology or Dermatology?

Ophthalmology base royalties range from 10.2% to 20.4%, while Dermatology royalties range from 6.5% to 13.1%. Royalty rates reflect pricing power, competitive dynamics, and patent protection characteristics specific to each therapeutic area.

What drives the deal value differences between ophthalmology and dermatology?

Key factors include addressable patient population size, clinical trial costs and timelines, regulatory pathway complexity, pricing and reimbursement dynamics, and competitive landscape density. Ophthalmology and Dermatology each have unique value drivers that shape deal economics.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Related Benchmarks

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,400+ biopharma licensing deals.

Start Calculating

For Funds & Advisors

Need a decision for one asset?

The Deal Intelligence Brief turns this landscape into a decision for one asset — a signed recommendation with ask, floor and walk-away, cited comparables, buyers ranked on evidence, and a 24-month catalyst calendar. Reviewed by the Managing Partner; delivered within 24 hours of the intake call.

Configure Brief — $2,500About 30 data-backed pages · Invoiced at intake · 30-minute walkthrough